Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk

Area of Science:

• Genetics
• Immunology
• Sarcoidosis Research

Background:

• Genetic variations contribute significantly to sarcoidosis etiology, yet much of its heritability remains unexplained.
• Identifying specific genetic risk factors is crucial for understanding sarcoidosis pathogenesis.

Purpose of the Study:

• To identify additional genetic risk loci for sarcoidosis using a candidate gene association study.
• To investigate immune-associated loci utilizing the Immunochip platform.

Main Methods:

• A two-stage genome-wide association study (GWAS) design involving over 19,000 individuals (1,726 cases, 5,482 controls in screening; 3,955 cases, 7,514 controls, 684 parents in validation/replication).
• Genotyping of 128,705 single-nucleotide polymorphisms (SNPs) using the Illumina Immunochip.
• Validation and replication of 44 candidate SNPs and 2 established risk SNPs.

Main Results:

• Identification of four novel sarcoidosis susceptibility loci with genome-wide significance on chromosomes 12q24.12, 5q33.3, 4q24, and 2q33.2.
• Confirmation of three independent association signals within the HLA region, including BTNL2, HLA-B, and HLA-DPB1.
• Discovery of a novel independent association signal near IL23R on chromosome 1p31.3.

Conclusions:

• Functional analyses suggest the IL23/Th17 signaling pathway plays a key role in the genetic basis of sarcoidosis.
• The identified genetic loci indicate a significant overlap between sarcoidosis and other immune-mediated inflammatory disorders.
• These findings have potential implications for the clinical application of targeted therapeutics in sarcoidosis management.